Our results in the ECC cells are in line with previous studies examining the predictive value of hENT1 for gemcitabine response in other solid tumors, including non-small-cell lung carcinoma (NSCLC) and PDAC. The gene discussed is SLC29A1; the disease is non-small cell lung carcinoma.